A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)
Clinical trial NCT05562947 · RECRUITING
Trial details
- NCT number
- NCT05562947
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2027-07-27
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.